Related references
Note: Only part of the references are listed.Mammalian target of rapamycin signaling in diabetic cardiovascular disease
Zhao Zhong Chong et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Administration of Pigment Epithelium-Derived Factor Inhibits Left Ventricular Remodeling and Improves Cardiac Function in Rats with Acute Myocardial Infarction
Shin-ichiro Ueda et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans
Nobuhiro Tahara et al.
ATHEROSCLEROSIS (2011)
Pigment Epithelium-Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase
Melissa L. Borg et al.
DIABETES (2011)
Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS)
Hirohito Sone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Significance of Plasma Levels of Pigment Epithelium-derived Factor as Determined by Multidetector Row Computed Tomography in Pitients with Mild Chronic Kidney Disease and/or Coronary Artery Disease
Y. Shiga et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Prognostic Value of Pigment Epithelium-Derived Factor in Patients With Advanced Heart Failure
Kathrin Rychli et al.
CHEST (2010)
Plasma Level of Pigment Epithelium-Derived Factor Is Independently Associated with the Development of the Metabolic Syndrome in Chinese Men: A 10-Year Prospective Study
Cheng Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pigment Epithelium-Derived Factor as a New Marker of Metabolic Syndrome in Caucasian Population
D. Stejskal et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Positive Association of Serum Levels of Pigment Epithelium-derived Factor with High-sensitivity C-reactive Protein in Apparently Healthy Unmedicated Subjects
H. Umei et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy
Binhui Wang et al.
MICROVASCULAR RESEARCH (2010)
Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders
Sho-ichi Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
Kathrin Rychli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: A possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes
Katsuhiko Takenaka et al.
ATHEROSCLEROSIS (2008)
Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications
Sho-ichi Yamagishi et al.
CURRENT DRUG TARGETS (2008)
Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation
Kazuo Nakamura et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29
K. Nakamura et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2007)
Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies
Apoor S. Gami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome
Sho-ichi Yamagishi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation
Parisa Zamiri et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
PEDF: anti-angiogenic guardian of ocular function
N Bouck
TRENDS IN MOLECULAR MEDICINE (2002)
Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor
OV Volpert et al.
NATURE MEDICINE (2002)